Myron Shulgan KC
Vermogen: 2 M $ op 31-07-2026
Vermogen: 2 M $ op 31-07-2026
Mr. Myron W.
Shulgan KC is an Independent Director at Drugs Made In America Acquisition II Corp.
and an Independent Director at Drugs Made In America Acquisition Corp.
He is on the Board of Directors at Drugs Made In America Acquisition II Corp.
and Drugs Made In America Acquisition Corp.
Mr. Shulgan KC was previously employed as a Partner by Sutts, Strosberg LLP.
He received his undergraduate degree from the University of Windsor and a graduate degree from the University of Windsor.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
0,41% | 15-04-2026 | 100.000 ( 0,41% ) | 1 M $ | 31-07-2026 |
0,16% | 26-09-2025 | 100.000 ( 0,16% ) | 1 M $ | 31-07-2026 |
| Bedrijven | Functie | Begin |
|---|
| Bedrijven | Functie | Einde |
|---|---|---|
Sutts, Strosberg LLP
Sutts, Strosberg LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | 01-01-2024 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 2 |
|---|---|
University of Windsor
University of Windsor Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sutts, Strosberg LLP
Sutts, Strosberg LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau